Cargando…

Meningococcal Serogroup A, C, W(135) and Y Conjugated Vaccine: A Cost-Effectiveness Analysis in the Netherlands

BACKGROUND: In 2002, vaccination with a serogroup C meningococcal conjugate vaccine (MenC) was introduced in the Netherlands for all children aged 14 months. Despite its success, herd immunity may wane over time. Recently, a serogroup A,C,W135,Y meningococcal conjugate vaccine (MenACWY) was licensed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hepkema, Hiltsje, Pouwels, Koen B., van der Ende, Arie, Westra, Tjalke A., Postma, Maarten J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669019/ https://www.ncbi.nlm.nih.gov/pubmed/23741448 http://dx.doi.org/10.1371/journal.pone.0065036

Ejemplares similares

The Clinical Picture and Severity of Invasive Meningococcal Disease Serogroup W Compared With Other Serogroups in the Netherlands, 2015–2018
por: Loenenbach, Anna D, et al.
Publicado: (2020)

Serogroup W135 Meningococcal Disease, The Gambia, 2012
por: Hossain, M. Jahangir, et al.
Publicado: (2013)

Serogroup W-135 Meningococcal Disease during the Hajj, 2000
por: Lingappa, Jairam R., et al.
Publicado: (2003)

Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands
por: Kaaijk, Patricia, et al.
Publicado: (2012)

Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018
por: Knol, Mirjam J, et al.
Publicado: (2018)

Serogroup W135 Meningococcal Meningitis, Northern Cameroon, 2007–2008
por: Massenet, Denis, et al.
Publicado: (2009)

Cluster of Serogroup W-135 Meningococcal Disease in 3 Military Recruits
por: Jo, Yu Mi, et al.
Publicado: (2015)

Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease
por: Hedari, Carine P, et al.
Publicado: (2014)

Cost-effectiveness of a male catch-up human papillomavirus vaccination program in the Netherlands
por: Simons, Joost J.M., et al.
Publicado: (2022)

Vaccine Impact and Effectiveness of Meningococcal Serogroup ACWY Conjugate Vaccine Implementation in the Netherlands: A Nationwide Surveillance Study
por: Ohm, Milou, et al.
Publicado: (2021)

Outbreak of Serogroup W135 Meningococcal Disease after the Hajj Pilgrimage, Europe, 2000
por: Aguilera, Jean-François, et al.
Publicado: (2002)

Meningococcal W135 Disease Vaccination Intent, the Netherlands, 2018–2019
por: de Vries, Marion, et al.
Publicado: (2020)

Increase of invasive meningococcal serogroup W disease in Europe, 2013 to 2017
por: Krone, Manuel, et al.
Publicado: (2019)

W135 Meningococcal Disease in Africa
por: Pollard, Andrew J., et al.
Publicado: (2003)

Induction of salivary antibody levels in Dutch adolescents after immunization with monovalent meningococcal serogroup C or quadrivalent meningococcal serogroup A, C, W and Y conjugate vaccine
por: van Ravenhorst, Mariëtte B., et al.
Publicado: (2018)

Neisseria meningitidis Serogroup W135, China
por: Shao, Zhujun, et al.
Publicado: (2010)

An Updated Analysis of the Impact of HPV Vaccination Based on Long-term Effectiveness in the Netherlands
por: Luttjeboer, Jos, et al.
Publicado: (2023)

Pericarditis due to Neisseria meningitidis serogroup W135
por: Shinha, Takashi, et al.
Publicado: (2018)

Cost-Effectiveness of Adolescent Pertussis Vaccination for The Netherlands: Using an Individual-Based Dynamic Model
por: de Vries, Robin, et al.
Publicado: (2010)

Necrotising fasciitis as atypical presentation of infection with emerging Neisseria meningitidis serogroup W (MenW) clonal complex 11, the Netherlands, March 2017
por: Russcher, Anne, et al.
Publicado: (2017)

Critical appraisal of a quadrivalent CRM(197) conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo(®)) in the context of treatment and prevention of invasive disease
por: Bröker, Michael, et al.
Publicado: (2011)

Carriage of Neisseria meningitidis Serogroup W135 ST-2881
por: Boisier, Pascal, et al.
Publicado: (2006)

Increase in Neisseria meningitidis Serogroup W135, Niger, 2010
por: Collard, Jean-Marc, et al.
Publicado: (2010)

Hajj-Related Neisseria Meningitidis Serogroup W135 in Mauritius
por: Issack, Mohammad Iqbal, et al.
Publicado: (2002)

Meningitis Serogroup W135 Outbreak, Burkina Faso, 2002
por: Nathan, Nicolas, et al.
Publicado: (2007)

Increase in Meningococcal Serogroup W Disease, Victoria, Australia, 2013–2015
por: Carville, Kylie S., et al.
Publicado: (2016)

Atypical presentation of invasive meningococcal disease caused by serogroup W meningococci
por: Stinson, C., et al.
Publicado: (2020)

The immunogenicity and safety of an investigational meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (ACWY-TT) compared with a licensed meningococcal tetravalent polysaccharide vaccine: A randomized, controlled non-inferiority study
por: Dbaibo, Ghassan, et al.
Publicado: (2012)

A randomized study to assess the immunogenicity, antibody persistence and safety of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in children aged 2–10 years
por: Vesikari, Timo, et al.
Publicado: (2012)

Clinical features and outcome of sporadic serogroup W135 disease Taiwan
por: Wang, Jiun-Ling, et al.
Publicado: (2006)

Cluster of Serogroup W135 Meningococci, Southeastern Florida, 2008–2009
por: Doyle, Timothy J., et al.
Publicado: (2010)

Travel-related Neisseria meningitidis Serogroup W135 Infection, France
por: Taha, Muhamed-Kheir, et al.
Publicado: (2013)

Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013
por: Gamougam, Kadidja, et al.
Publicado: (2015)

Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil
por: Tauil, Márcia de Cantuária, et al.
Publicado: (2014)

Immune response, antibody persistence, and safety of a single dose of the quadrivalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine in adolescents and adults: results of an open, randomised, controlled study
por: Borja-Tabora, Charissa, et al.
Publicado: (2013)

Effect of a serogroup A meningococcal conjugate vaccine (PsA–TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study
por: Daugla, DM, et al.
Publicado: (2013)

Meningococcal disease serogroup C
por: Dickinson, Félix O, et al.
Publicado: (2012)

The investigational meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (ACWY-TT) and the seasonal influenza virus vaccine are immunogenic and well-tolerated when co-administered in adults
por: Reyes, Mari Rose Aplasca-De Los, et al.
Publicado: (2012)

Current Epidemiology of Serogroup W Meningococcal Disease—United States, 2010–2015
por: Soeters, Heidi, et al.
Publicado: (2017)

Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers
por: Vesikari, Timo, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_k3tpvbpt1b5j4cickrkldt4p7t